VIM and breast carcinoma: In the TCGA dataset, we assessed the expression of key epithelial marker E-cadherin (CDH1) and mesenchymal markers, including vimentin (VIM), MMP9, SNAI2, ZEB1, and ZEB2, about VISTA expression in breast cancer patients using Spearman correlation analysis (Figure 5).